Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy: Risk-modifying factors;Spätnebenwirkungen der Bestrahlung, kosmetisches Ergebnis und Schmerzen bei Brustkrebspatientinnen nach brusterhaltender Chirurgie und dreidimensionaler konformaler Strahlentherapie: Risikomodifizierende Faktoren

Strahlentherapie und Onkologie

Volumn 192, Issue 1, 2016, Pages 8-16

  Hille Betz, Ursula ^a   Vaske, Bernhard ^a   Bremer, Michael ^a   Soergel, Philipp ^a   Kundu, Sudip ^a   Klapdor, Rüdiger ^a   Hillemanns, Peter ^a   Henkenberens, Christoph ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Breast conserving therapy; Cosmesis; Late side effects; Quality of life; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ARM EDEMA; ARM PAIN; ARTICLE; BREAST CANCER; BREAST EDEMA; CANCER PATIENT; COMPUTER ASSISTED RADIOTHERAPY; DISEASE SEVERITY; ESTHETICS; FEMALE; FIBROSIS; HUMAN; INTRADUCTAL CARCINOMA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTALGIA; PARTIAL MASTECTOMY; PTOSIS; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; SHOULDER PAIN; TELANGIECTASIA; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; BREAST; BREAST NEOPLASMS; BREAST RECONSTRUCTION; CONFORMAL RADIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; RADIATION INJURIES; RADIATION RESPONSE; SEGMENTAL MASTECTOMY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ESTHETICS; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL;

EID: 84953346259     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-015-0899-y     Document Type: Article

References (40)

1. Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232. doi:10.1056/NEJMoa020989
2. Goffman TE, Laronga C, Wilson L et al (2004) Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 10:405–411. doi:10.1111/j.1075-122X.2004.21411.x
3. Pusic AL, Cemal Y, Albornoz C et al (2013) Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 7:83–92. doi:10.1007/s11764-012-0247-5
4. Mansfield C (1979) Effects of radiation therapy on wound healing after mastectomy. Clin Plast Surg 6:19–26
5. Fajardo LF (1993) Basic mechanisms and general morphology of radiation injury. Semin Roentgenol 28:297–302
6. Mukesh MB, Barnett GC, Wilkinson JS et al (2013) Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31:4488–4495. doi:10.1200/JCO.2013.49.7842
7. Taylor ME, Perez CA, Halverson KJ et al (1995) Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31:753–764. doi:10.1016/0360-3016(94)00480-3
8. Vrieling C, Collette L, Fourquet A et al (2000) The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‛boost vs. no boost’ trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. Radiother Oncol 55:219–232
9. Asgeirsson KS, Rasheed T, McCulley SJ et al (2005) Oncological and cosmetic outcomes of oncoplastic breast conserving surgery. Eur J Surg Oncol 31:817–823. doi:10.1016/j.ejso.2005.05.010
10. Rezai M, Nestle-Krämling C (1999) Oncoplastic surgical techniques in breast-conserving therapy for carcinoma of the breast. Gynäkologe 32:83–90. doi:10.1007/PL00003213
11. Hille-Betz U, Vaske B, Henseler H et al (2014) Dermoglandular rotation flaps for breast-conserving therapy: aesthetic results, patient satisfaction, and morbidity in comparison to standard segmentectomy. Int J Breast Cancer 2014:152451. doi:10.1155/2014/152451
12. Clough KB, Lewis JS, Couturaud B et al (2003) Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg 237:26–34. doi:10.1097/01.SLA.0000041230.77663.22
13. International Commission on Radiation Units and Measurements (icru) ICRU Report 62. Bethesda: ICRU; 1999. Prescribing, Recording and Reporting Photon Beam Therapy [supplement to ICRU Report 50]
14. Regnault P (1976) Breast ptosis. Definition and treatment. Clin Plast Surg 3:193–203
15. Cardoso MJ, Cardoso J, Amaral N et al (2007) Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. Breast 16:456–461. doi:10.1016/j.breast.2007.05.002
16. Pavy JJ, Denekamp J, Letschert J et al (1995) EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 31:1043–1047
17. Sprangers MA, Groenvold M, Arraras JI et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768
18. Kwan W, Jackson J, Weir LM et al (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:4242–4248
19. Ahmed RL, Prizment A, Lazovich D et al (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol 26:5689–5696. doi:10.1200/JCO.2008.16.4731
20. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609. doi:10.1093/jnci/djj158
21. Del Bianco P, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34:508–513. doi:10.1016/j.ejso.2007.05.017
22. Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663. doi:10.1200/JCO.2006.07.4062
23. Degnim AC, Miller J, Hoskin TL et al (2012) A prospective study of breast lymphedema: frequency, symptoms, and quality of life. Breast Cancer Res Treat 134:915–922. doi:10.1007/s10549-012-2004-x
24. Kelemen G, Varga Z, Lázár G et al (2012) Cosmetic outcome 1–5 years after breast conservative surgery, irradiation and systemic therapy. Pathol Oncol Res 18:421–427. doi:10.1007/s12253-011-9462-z
25. Chadha M, Vongtama D, Friedmann P et al (2012) Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer 12:57–62. doi:10.1016/j.clbc.2011.09.002
26. Barnett GC, Wilkinson JS, Moody AM et al (2011) The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity. Clinical Oncol (R Coll Radiol) 23:662–673. doi:10.1016/j.clon.2011.04.011
27. Mondry TE, Johnstone, Peter AS (2002) Manual lymphatic drainage for lymphedema limited to the breast. J Surg Oncol 81:101–104. doi:10.1002/jso.10154
28. Lilla C, Ambrosone CB, Kropp S et al (2007) Predictive factors for late normal tissue complications following radiotherapy for breast cancer. Breast Cancer Res Treat 106:143–150. doi:10.1007/s10549-006-9480-9
29. Bantema-Joppe EJ, Schilstra C, de Bock, Geertruida H et al (2012) Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months’ follow-up. Int J Radiat Oncol Biol Phys 83:e471–e477. doi:10.1016/j.ijrobp.2012.01.050
30. Johansson S, Svensson H, Denekamp J (2002) Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer atients. Int J Radiat Oncol Biol Phys 52:1207–1219
31. Ohsumi S, Shimozuma K, Kuroi K et al (2007) Quality of life of breast cancer patients and types of surgery for breast cancer—current status and unresolved issues. Breast Cancer 14:66–73
32. Clark RM (1983) Conservative surgery and radiation therapy in the treatment of operable breast cancer. Front Radiat Ther Oncol 17:91–101
33. Budach W, Matuschek C, Bolke E et al (2015) DEGRO practical guidelines for radiotherapy of breast cancer V. Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases (DEGRO-Leitlinien fur die Radiotherapie des Mammakarzinoms V: Therapie des lokal fortgeschrittenen und inflammatorischen Mammakarzinoms sowie lokale Therapie bei Vorliegen synchroner Fernmetastasen). Strahlenther Onkol. doi:10.1007/s00066-015-0843-1
34. Bergom C, Kelly T, Morrow N et al (2012) Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts. Int J Radiat Oncol Biol Phys 83:821–828. doi 10.1016/j.ijrobp.2011.08.020
35. Würschmidt F, Stoltenberg S, Kretschmer M et al (2014) Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation. A dosimetric comparison in adjuvant radiotherapy of early stage breast cancer. Strahlenther Onkol 190:563–568. doi:10.1007/s00066-014-0606-4
36. Meretoja TJ, Leidenius, Marjut H K, Tasmuth T et al (2014) Pain at 12 months after surgery for breast cancer. JAMA 311:90–92. doi:10.1001/jama.2013.278795
37. Hamilton CS, Nield JM, Adler GF et al (1990) Breast appearance and function after breast conserving surgery and radiotherapy. Acta Oncol 29:291–295
38. Poleshuck EL, Katz J, Andrus CH et al (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7:626–634. doi:10.1016/j.jpain.2006.02.007
39. Ishiyama H, Niino K, Hosoya T et al (2006) Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy. Breast Cancer 13:197–201
40. Mak KS, Chen Y, Catalano PJ et al (2014) Dosimetric inhomogeneity predicts for long-term breast pain after breast-conserving therapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2014.05.021